101440
论文已发表
提 交 论 文
注册即可获取Ebpay生命的最新动态
注 册
IF 收录期刊
- 3.3 Breast Cancer (Dove Med Press)
- 3.4 Clin Epidemiol
- 2.5 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.5 Clin Interv Aging
- 4.7 Drug Des Dev Ther
- 2.7 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.5 Int J Women's Health
- 2.5 Neuropsych Dis Treat
- 2.7 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.3 Ther Clin Risk Manag
- 2.5 J Pain Res
- 2.8 Diabet Metab Synd Ob
- 2.8 Psychol Res Behav Ma
- 3.0 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.7 Risk Manag Healthc Policy
- 4.2 J Inflamm Res
- 2.1 Int J Gen Med
- 4.2 J Hepatocell Carcinoma
- 3.7 J Asthma Allergy
- 1.9 Clin Cosmet Investig Dermatol
- 2.7 J Multidiscip Healthc
Giant cell arteritis: early diagnosis is key
Authors Baig IF, Pascoe AR, Kini A, Lee AG
Received 14 August 2018
Accepted for publication 27 November 2018
Published 17 January 2019 Volume 2019:11 Pages 1—12
DOI http://doi.org/10.2147/EB.S170388
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Professor Margaret Wong-Riley
Abstract: Giant
cell arteritis (GCA) is an inflammatory vasculitis typically affecting elderly
that can potentially cause vision loss. Studies have demonstrated that early
recognition and initiation of treatment can improve visual prognosis in
patients with GCA. This review addresses the benefits of early diagnosis and
treatment, and discusses the available treatment options to manage the disease.
Keywords: giant
cell arteritis, imaging in GCA, laboratory values in GCA, steroids in GCA,
steroid-sparing agents in GCA
摘要视频链接：Giant cell
arteritis: early diagnosis is key
